查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肿瘤切除的全球市场(2022年～2028年)
市场调查报告书
商品编码
1215557

肿瘤切除的全球市场(2022年～2028年)

Tumor Ablation Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3个工作天内

价格

全球肿瘤切除的市场规模，在预测期间内预计以约12.7％大幅度的年复合成长率成长。癌症疾病的盛行率增加，是促进市场成长的显着要素之一。再加上快速的回復，併发症的减少，住院期间的缩短等，肿瘤切除所提供的各种优点，这个技术今后数年预计气势渐增。

本报告提供全球肿瘤切除市场相关调查，市场概要，各市场区隔分析，竞争情形，企业简介等资讯。

目录

第1章 报告概要

第2章 市场概要与洞察

  • 调查范围
  • 分析师的洞察和目前市场趋势

第3章 竞争情形

  • 主要企业分析

第4章 市场区隔

  • 全球肿瘤切除市场:各技术
    • 射频消融术
    • 微波切除
    • 冷冻切除
    • 经皮乙醇切除
  • 全球肿瘤切除市场:各用途
    • 肝臟癌症
    • 肺癌症
    • 乳癌
    • 前列腺癌症
    • 其他
  • 全球肿瘤切除市场:各终端用户
    • 医院
    • 外科诊所
    • 研究机关

第5章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的亚太地区
  • 其他地区

第6章 企业简介

  • Afreeze GmbH
  • Alpinion Medical Systems
  • Atricure
  • ATS Medical, Inc.
  • Biosig Technologies, Inc.
  • Biotronik Se & Co. Kg
  • Boston Scientific Corp.
  • BTG plc
  • BVM Medical Ltd
  • Erbe Elektromedizin GmbH
  • Healthtronics, Inc.
  • Hologic Inc.
  • Icecure Medical Ltd
  • Integra Lifesciences
  • Koninklijke Philips N.V
  • Medtronic Plc
  • Medwaves Inc.
  • Pentax Medical
  • Stryker
Product Code: OMR2026613

Title:Global Tumor Ablation Market Size, Share & Trends Analysis Report by Technology (Radio Frequency Ablation, Microwave Ablation, Cryoablation, and Percutaneous Ethanol Ablation) by Application (Liver Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, and Others) by End-User (Hospitals, Surgical Clinics, and Research Institutions) Forecast 2022-2028.

The global tumor ablation market is anticipated to grow at a substantial CAGR of around 12.7% during the forecast period. The increasing prevalence of cancer diseases is one of the prominent factors driving the market growth. Furthermore, various advantages offered by tumor ablation techniques such as speedy recovery, reduced complication, and shorter hospitals stay, the technique is gaining traction in coming years. Tumor ablation refers to a minimally invasive (MI) technique used for the treatment of tumors of the kidney, liver, and lungs. It is conducted through microwave ablation, radiofrequency ablation, cryoablation, and others. Moreover, the rising number of brain tumors, and government initiatives to create awareness related to various cancers, boost the market growth. Brain tumors comprise a wide range of central nervous system tumors that ranges from non-malignant tumors to most complex cancers such as glioblastoma and diffuse intrinsic pontine glioma. According to the National Brain Tumor Society, an estimated 700,000 people in the US are living with a primary brain tumor, and nearly 90,000 more is diagnosed in 2022. Moreover, the average survival rate for all malignant brain tumor patients is only 36%, and it is one of the major causes of death in children and young adults aged 19 and younger.

The global tumor ablation market is segmented on the basis on technology, application, and end user. Based on technology, the market is sub-segmented into radio frequency ablation, microwave ablation, cryoablation, and percutaneous ethanol ablation. Based on application, the market is bifurcated into liver cancer, lung cancer, breast cancer, prostate cancer, and others. Based on end user, the market is sub-divided into hospitals, surgical clinics, and research institutions. Based on technology, the microwave ablation segment is holding a major share from its inception. Microwave ablation systems are gaining popularity over conventional surgeries to treat or destroy cancerous cells, and this procedure offers many advantages over conventional and other techniques, which increases the demand for microwave ablation in coming years.

Geographically market is segmented into: North America, Europe, Asia Pacific, and the Rest of the World. The European region is anticipated to grow at the fastest rate; presence of immense healthcare institutions, and the availability of advanced and innovative technological medical tools and devices for the tumor treatment, enhances the growth of the global tumor ablation market in the region. Moreover, the insurance coverage and benefits given by key insurance companies such as, Axa, Allianz SE, and Zurich Insurance Group, to people for treating major diseases which include tumor and diabetes, results in boosting the market growth.

The major companies serving the global tumor ablation market are Boston Scientific Corp., BTG plc, BVM Medical Ltd., Erbe Elektromedizin GmbH, Healthtronics, Inc., Hologic Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2022, Engenious and Precision Microwave have developed a new system for minimally invasive thermal ablation treatment for cancers, a novel treatment tool with the ability to reduce the risk of tumors. Thermal ablation is a type of procedure that uses heat, cold, microwave, and electrical currents to vaporize cancer cells and tumors.

Research Methodology

The market study of the global tumor ablation market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Tumor Ablation Market Research And Analysis by Technology
  • Global Tumor Ablation Market Research and Analysis by Application
  • Global Tumor Ablation Market Research and Analysis by End User

The Report Covers:

  • Comprehensive research methodology of the global tumor ablation market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global tumor ablation market.
  • Insights about market determinants that are stimulating the global tumor ablation market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Tumor Ablation Market
  • Recovery Scenario of Global Tumor Ablation Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis

4. Market Segmentation

  • 4.1. Global Tumor Ablation Market by Technology
    • 4.1.1. Radio Frequency Ablation
    • 4.1.2. Microwave Ablation
    • 4.1.3. Cryoablation
    • 4.1.4. Percutaneous Ethanol Ablation
  • 4.2. Global Tumor Ablation Market by Application
    • 4.2.1. Liver Cancer
    • 4.2.2. Lung Cancer
    • 4.2.3. Breast Cancer
    • 4.2.4. Prostate Cancer
    • 4.2.5. Others
  • 4.3. Global Tumor Ablation Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Surgical Clinics
    • 4.3.3. Research Institutions

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Afreeze GmbH
  • 6.2. Alpinion Medical Systems
  • 6.3. Atricure
  • 6.4. ATS Medical, Inc.
  • 6.5. Biosig Technologies, Inc.
  • 6.6. Biotronik Se & Co. Kg
  • 6.7. Boston Scientific Corp.
  • 6.8. BTG plc
  • 6.9. BVM Medical Ltd
  • 6.10. Erbe Elektromedizin GmbH
  • 6.11. Healthtronics, Inc.
  • 6.12. Hologic Inc.
  • 6.13. Icecure Medical Ltd
  • 6.14. Integra Lifesciences
  • 6.15. Koninklijke Philips N.V
  • 6.16. Medtronic Plc
  • 6.17. Medwaves Inc.
  • 6.18. Pentax Medical
  • 6.19. Stryker

LIST OF TABLES

  • 1. GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028($ MILLION)
  • 2. GLOBAL RADIO FREQUENCY ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 3. GLOBAL MICROWAVE ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 4. GLOBAL CRYOABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 5. GLOBAL PERCUTANEOUS ETHANOL ABLATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 6. GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
  • 7. GLOBAL LIVER CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 8. GLOBAL LUNG CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 9. GLOBAL BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 10. GLOBAL PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 11. GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 12. GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 13. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 14. GLOBAL SURGICAL CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 15. GLOBAL RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 16. GLOBAL TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028($ MILLION)

17. NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION

  • 18. NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028($ MILLION)
  • 19. NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
  • 20. NORTH AMERICA TUMOR ABLATION MARKET RESEARCH AND ANALYSIS, BY END-USER, 2021-2028($ MILLION)
  • 21. EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 22. EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028($ MILLION)
  • 23. EUROPE TUMOR ABLATION MARKET, MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
  • 24. EUROPE TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 25. ASIA-PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 26. ASIA-PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028($ MILLION)
  • 27. ASIA-PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028($ MILLION)
  • 28. ASIA PACIFIC TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 29. REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD TUMOR ABLATION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

 

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL TUMOR ABLATION MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL TUMOR ABLATION MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL TUMOR ABLATION MARKET, 2022-2028 (%)
  • 4. GLOBAL TUMOR ABLATION MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
  • 5. GLOBAL RADIO FREQUENCY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL MICROWAVE INHIBITORS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL CRYOABLATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL PERCUTANEOUS ETHANOL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL CRYOABLATION INHIBITORS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL TUMOR ABLATION MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 11. GLOBAL LIVER CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL LUNG CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL BREAST CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL PROSTATE CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. GLOBAL OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. GLOBAL TUMOR ABLATION MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 17. GLOBAL HOSPITALS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 18. GLOBAL SURGICAL CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 19. GLOBAL RESEARCH INSTITUTIONS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 20. US TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. CANADA TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. UK TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. FRANCE TUMOR ABLATIONMARKET SIZE, 2021-2028 ($ MILLION)
  • 24. GERMANY TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. ITALY TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SPAIN TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF EUROPE TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. INDIA TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. CHINA TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. JAPAN TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. SOUTH KOREA TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. REST OF THE WORLD TUMOR ABLATION MARKET SIZE, 2021-2028 ($ MILLION)